Status:
COMPLETED
The Feasibility of Drug Delivery to Infants During Breastfeeding
Lead Sponsor:
Cambridge University Hospitals NHS Foundation Trust
Collaborating Sponsors:
University of Cambridge
Conditions:
Medication Systems
Breast Feeding
Eligibility:
All Genders
7-12 years
Phase:
NA
Brief Summary
Parents commonly find giving medicines to babies, using oral syringes or spoons, difficult and emotionally stressful. In developing countries, additional stress arises due to hygiene difficulties and ...
Eligibility Criteria
Inclusion
- No known allergy or hypersensitivity against any ingredient used in the study Infant aged up to 12 months Confident breastfeeder (exclusively or non-exclusively)
Exclusion
- The participant may not enter the study if ANY of the following apply:
- Not confident at breastfeeding
- Infant not feeding properly
- Allergy or hypersensitivity against any ingredient of the commercially available Methylcobalamin Vitamin B12 Tablets (Just Vitamins Ltd, UK) used in the study (infant or mother)
- Medical conditions that could negatively influence swallowing, and thus breastfeeding
Key Trial Info
Start Date :
July 9 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT03799367
Start Date
July 9 2018
End Date
December 31 2018
Last Update
January 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
addenbrookes Hospital
Cambridge, United Kingdom